- Home
- AYI vs ARWR Comparison
AYI vs ARWR Comparison
Compare AYI & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AYI | ARWR |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 10.2B |
| IPO Year | 2001 | 2009 |
Fundamental Metrics
Financial Performance| Metric | AYI | ARWR |
|---|---|---|
| Price | $327.04 | $85.45 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $369.17 | $83.40 |
| AVG Volume (30 Days) | 399.3K | ★ 2.4M |
| Earning Date | 04-02-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.28% | N/A |
| EPS Growth | N/A | ★ 99.80 |
| EPS | ★ 11.45 | N/A |
| Revenue | ★ $3,461,000,000.00 | $16,142,321.00 |
| Revenue This Year | $7.51 | N/A |
| Revenue Next Year | $5.14 | N/A |
| P/E Ratio | $28.50 | ★ N/A |
| Revenue Growth | ★ 4.05 | N/A |
| 52 Week Low | $257.04 | $15.01 |
| 52 Week High | $380.17 | $95.49 |
Technical Indicators
Market Signals| Indicator | AYI | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 48.65 | 59.26 |
| Support Level | $324.00 | $70.03 |
| Resistance Level | $376.46 | $86.19 |
| Average True Range (ATR) | 10.37 | 4.14 |
| MACD | -3.03 | 0.84 |
| Stochastic Oscillator | 9.43 | 60.82 |
Price Performance
Historical ComparisonAbout AYI Acuity Brands Inc.
Acuity is a leading industrial technology company that offers lighting, lighting controls, and intelligent building solutions. It designs, manufactures, and brings to market products and services relating to these and other offerings. Acuity has two reportable segments: Acuity Brands Lighting and Acuity Intelligent Spaces. ABL sells commercial, architectural, and specialty lighting, including components and control systems. AIS offers building management and audio/visual solutions to help make buildings intelligent.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.